| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/14/1999 | EP0907357A1 Non-aqueous controlled release pest and air care gel composition |
| 04/14/1999 | EP0907356A1 Aerodynamically light particles for pulmonary drug delivery |
| 04/14/1999 | EP0738252B1 Polyol composition produced by co-spray-drying |
| 04/14/1999 | EP0737063B1 Method for preparing liposomes without using an organic solvent |
| 04/14/1999 | EP0683760B1 Dehydrogenation processes and equipment therefor |
| 04/14/1999 | EP0680320B1 Stable oral ci-981 formulation and process of preparing same |
| 04/14/1999 | EP0605497B2 Medication vehicles made of solid lipid particles (solid lipid nanospheres - sln) |
| 04/14/1999 | CN2313583Y Pills made of single Chinese medicine |
| 04/14/1999 | CN2313582Y Chinese medicine cap |
| 04/14/1999 | CN1214062A Conductive adhesive prepared from zwitterionic materials |
| 04/14/1999 | CN1213971A Thermally stabilized contrast agent |
| 04/14/1999 | CN1213963A Method of producing morphologically uniform microcapsules and microcapsules produced by this method |
| 04/14/1999 | CN1213962A Method for solubilising hydrophylic materials (E. G. proteins) in hydrophobic solvent |
| 04/14/1999 | CN1213564A Chinese medicinal pills for treating catarct and its prodn. method |
| 04/14/1999 | CN1213563A Chenxia medicament for relieving asthma and its pren. tech. |
| 04/14/1999 | CN1213559A External-use plaster for cooling and bring down fever, its preparing method and use |
| 04/14/1999 | CN1213556A Method for preparing Chinese herbal medicine capsule |
| 04/14/1999 | CN1213554A Gu'anning ointment for treating hyperosteogeny and its prepn. method |
| 04/14/1999 | CN1213549A Vanilla ointment matrix |
| 04/14/1999 | CN1213545A Bishuping granular instant powder for treating nasal disease |
| 04/14/1999 | CN1213540A Plaster for treating hyperosteogeny and its prepn. method |
| 04/14/1999 | CN1213538A Method of preparing fast-releasing and slowly-releasing solid dispersion micropill in liquid phase |
| 04/14/1999 | CN1213537A Novel oral cavity medicine |
| 04/14/1999 | CN1213536A Super-oxygen Chinese medicinal oral liquid |
| 04/13/1999 | US5894022 Useful for blockage of vasculature feeding tumors; by cutting blood supply, growth of invasive tumors can be reduced or stopped |
| 04/13/1999 | US5894019 Topically applied pharmaceutical composition, method of preparing it and its use |
| 04/13/1999 | US5894017 Delivery system for an oral care substance using a strip of material having low flexural stiffness |
| 04/13/1999 | US5893974 Inorganic porous shell provoding a selective molecular barrier between interior and exterior |
| 04/13/1999 | CA2147260C Dry powder inhaler |
| 04/13/1999 | CA2116799C Solid form xerostomia product |
| 04/13/1999 | CA2068216C Lipospheres for controlled delivery of substances |
| 04/13/1999 | CA2005987C Therapeutically active substituted benzimidazole and process for its preparation |
| 04/08/1999 | WO1999017120A1 Preparing conjugates using polyethylene glycol linkers |
| 04/08/1999 | WO1999016472A1 Stable compositions containing biologically active components |
| 04/08/1999 | WO1999016471A1 O/w emulsion compositions |
| 04/08/1999 | WO1999016470A1 Oral preparation |
| 04/08/1999 | WO1999016468A1 Antigen vectors in the form of multilamellar vesicles |
| 04/08/1999 | WO1999016459A1 Apolipoprotein a-i agonists and their use to treat dyslipidemic disorders |
| 04/08/1999 | WO1999016454A1 Pharmaceutical composition for the treatment of inflammatory bowel disease |
| 04/08/1999 | WO1999016448A1 Sustained-release theophylline tablet |
| 04/08/1999 | WO1999016447A1 Aqueous preparation containing antiviral agent having purine or pyrimidine skeleton |
| 04/08/1999 | WO1999016443A1 Oral compositions of levosimendan |
| 04/08/1999 | WO1999016442A2 Sustained release tablet formulation to treat parkinson disease |
| 04/08/1999 | WO1999016440A1 Amorphous paroxetine composition |
| 04/08/1999 | WO1999016439A1 CHRONIC, BOLUS ADMINISTRATION OF D-threo METHYLPHENIDATE |
| 04/08/1999 | WO1999016436A1 Pharmaceutical composition for the treatment of inflammatory bowel disease and irritable bowel syndrome |
| 04/08/1999 | WO1999016434A1 A transdermal drug delivery system for anti-inflammatory analgesic agent comprising diclofenac diethylammonium salt, and the manufacturing method thereof |
| 04/08/1999 | WO1999016428A1 Method for preventing the misuse of a transdermal therapeutic system |
| 04/08/1999 | WO1999016427A1 Active agent transport systems |
| 04/08/1999 | WO1999016426A2 Multilamellar coalescence vesicles (mlcv) containing biologically active compounds |
| 04/08/1999 | WO1999016425A1 Lipid-modified insulin incorporated liposomes for selectively delivering cytotoxic agents to hepatoma cells |
| 04/08/1999 | WO1999016424A1 Anti-inflammatory pharmaceutical formulation |
| 04/08/1999 | WO1999016423A1 Use of biologically active glass as a drug delivery system |
| 04/08/1999 | WO1999016422A1 Stabilized preparations for use in metered dose inhalers |
| 04/08/1999 | WO1999016421A1 Stabilized bioactive preparations and methods of use |
| 04/08/1999 | WO1999016420A1 Stabilized preparations for use in nebulizers |
| 04/08/1999 | WO1999016419A1 Perforated microparticles and methods of use |
| 04/08/1999 | WO1999016418A1 Acidic aqueous chlorite teat dip providing shelf life, sanitizing capacity and tissue protection |
| 04/08/1999 | WO1999016417A1 Buccal, polar and non-polar spray or capsule |
| 04/08/1999 | WO1999016412A2 Non-irritating cosmetic and pharmaceutical compositions |
| 04/08/1999 | WO1999016411A1 Dermatologic preparation |
| 04/08/1999 | WO1999016408A2 Apolipoprotein a-i agonists and their use to treat dyslipidemic disorders |
| 04/08/1999 | WO1999016313A1 2-methyl-thieno-benzodiazepine formulation |
| 04/08/1999 | WO1999016309A1 Acidic aqueous chlorite teat dip providing shelf life, sanitizing capacity and tissue protection |
| 04/08/1999 | WO1999009066B1 Preparation of pregelatinized high amylose starch and debranched starch useful as an excipient for controlled release of active agents |
| 04/08/1999 | WO1999005989A3 Devices for providing therapeutic substances |
| 04/08/1999 | WO1999004768A3 Osmotic delivery system flow modulator apparatus |
| 04/08/1999 | WO1999004762A3 Entrapping additives in carbohydrate bodies |
| 04/08/1999 | WO1999003508A3 METHOD FOR TREATING VASCULAR PROLIFERATIVE DISEASES WITH p27 AND FUSIONS THEREOF |
| 04/08/1999 | WO1999000113A9 Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof |
| 04/08/1999 | WO1998055105A9 Fibrinogen-coated microspheres |
| 04/08/1999 | WO1998055103A9 Anti-tumoral therapy agent |
| 04/08/1999 | DE19740983A1 Solid oral formulation based on ephedrine and similar compounds containing fats or gel forming agents and surfactants making isolation difficult |
| 04/08/1999 | CA2305179A1 Oral administration preparation |
| 04/08/1999 | CA2304951A1 Active agent transport systems |
| 04/08/1999 | CA2304931A1 Apolipoprotein a-i agonists and their use to treat dyslipidemic disorders |
| 04/08/1999 | CA2304824A1 Antigen vectors in the form of multilamellar vesicles and compositions containing antigens encapsulated in these vesicles |
| 04/08/1999 | CA2304805A1 Apolipoprotein a-i agonists and their use to treat dyslipidemic disorders |
| 04/08/1999 | CA2304594A1 Amorphous paroxetine composition |
| 04/08/1999 | CA2304516A1 Pharmaceutical composition for the treatment of inflammatory bowel disease and irritable bowel syndrome |
| 04/08/1999 | CA2301869A1 Sustained release tablet formulation to treat parkinson disease |
| 04/08/1999 | CA2273028A1 Stable compositions containing biologically active components |
| 04/07/1999 | EP0906951A2 Storage of materials |
| 04/07/1999 | EP0906754A1 Rapid-release s1452 tablets |
| 04/07/1999 | EP0906753A1 Effervescent preparation and process for producing the same |
| 04/07/1999 | EP0906724A1 Pseudoplastic film-forming acidic chlorite composition as teat dip |
| 04/07/1999 | EP0906421A1 Enhanced efficacy of liposomal antisense delivery |
| 04/07/1999 | EP0906262A1 Colchicine-skeleton compounds, their use as medicaments and compositions containing them |
| 04/07/1999 | EP0906243A1 Dissolvable oxides for biological applications |
| 04/07/1999 | EP0906127A1 Novel devices for transdermal administering of trimegestone |
| 04/07/1999 | EP0906124A2 Device and method for encapsulated gene therapy |
| 04/07/1999 | EP0906123A1 OLIGONUCLEOTIDES TARGETED TO ANGIOTENSINOGEN mRNA |
| 04/07/1999 | EP0906116A1 System and method for delivery of cytokines using encapsulated cytokine-secreting cells |
| 04/07/1999 | EP0906113A1 Process for preparing a storable preparation consisting of fresh plants, and fresh plant preparation |
| 04/07/1999 | EP0906112A2 Use of alkylaryl polyether alcohol polymers for the treatment of chronic pulmonary inflammation |
| 04/07/1999 | EP0906107A1 Compositions comprising an hiv protease inhibitor such as vx 478 and a water soluble vitamin e compound such as vitamin e-tpgs |
| 04/07/1999 | EP0906098A1 Virginiamycin mixture |
| 04/07/1999 | EP0906092A1 Pharmaceutical compositions based on diclofenac |
| 04/07/1999 | EP0906089A2 Buccal delivery system |
| 04/07/1999 | EP0906088A1 Liposomal antineoplaston therapies with markedly improved antineoplastic activity |